Drugs for Neglected Diseases initiative - DNDi
Lydia Manoti currently serves as the Global Philanthropy Manager for Drugs for Neglected Diseases initiative (DNDi). Prior to this role, Lydia held positions such as Business Development Manager at Save the Children International and Programme Manager at African Academy of Sciences. Lydia has extensive experience in resource mobilization, grants management, partnership development, and program planning in various nonprofit organizations. Lydia holds a Master of Arts in Projects Planning and Management from the University of Nairobi.
This person is not in any offices
Drugs for Neglected Diseases initiative - DNDi
2 followers
The Drugs for Neglected Diseases initiative (DNDi) is an international, not-for-profit research and development organization. We discover, develop, and deliver treatments for neglected patients around the world. Our treatments are affordable and patient-friendly – and have already saved millions of lives. We are researching new treatments for people living with Chagas disease, sleeping sickness (human African trypanosomiasis), leishmaniasis, filarial infections, mycetoma, paediatric HIV, hepatitis C, and dengue. Together with our partners, we are working on over 40 projects, including more than 20 new chemical entities. We are also running over 20 clinical trials. When the medical humanitarian organization Médecins Sans Frontières (MSF) won the Nobel Peace Prize in 1999, they dedicated a portion of the award to addressing this fatal imbalance and exploring a new, alternative, not-for-profit model for developing drugs for neglected patients. As a result in 2003, MSF, the World Health Organization, and five international research institutions founded DNDi.